CB1 receptor silencing attenuates Ketamine-induced hyperlocomotion without compromising its antidepressant-like effects (2023)
- Authors:
- USP affiliated authors: GUIMARÃES, FRANCISCO SILVEIRA - FMRP ; WEGENER, SÂMIA REGIANE LOURENÇO JOCA - FCFRP ; MARQUES, JADE DOS SANTOS - FCF ; NUNES, PEDRO HENRIQUE GOBIRA - FCFRP ; SARTIM, ARIANDRA GUERINI - FCFRP ; SILVEIRA, KENNIA MOURA - FCFRP
- Unidades: FMRP; FCFRP; FCF
- DOI: 10.1089/can.2022.0072
- Subjects: ANTIDEPRESSIVOS; ESTIMULANTES DO SISTEMA NERVOSO CENTRAL; CANABINOIDES; CAMUNDONGOS
- Keywords: Ketamine; CB1 cannabinoid receptors; Depression; Forced swim test; Hyperlocomotion
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: New Rochelle
- Date published: 2023
- Source:
- Título: Cannabis and Cannabinoid Research
- ISSN: 2578-5125
- Volume/Número/Paginação/Ano: v. 8, n. 5, p. 768-778, 2023
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
NUNES, Pedro Henrique Gobira et al. CB1 receptor silencing attenuates Ketamine-induced hyperlocomotion without compromising its antidepressant-like effects. Cannabis and Cannabinoid Research, v. 8, n. 5, p. 768-778, 2023Tradução . . Disponível em: https://doi.org/10.1089/can.2022.0072. Acesso em: 02 dez. 2025. -
APA
Nunes, P. H. G., LaMar, J., Marques, J. dos S., Sartim, A. G., Silveira, K. M., Santos, L., et al. (2023). CB1 receptor silencing attenuates Ketamine-induced hyperlocomotion without compromising its antidepressant-like effects. Cannabis and Cannabinoid Research, 8( 5), 768-778. doi:10.1089/can.2022.0072 -
NLM
Nunes PHG, LaMar J, Marques J dos S, Sartim AG, Silveira KM, Santos L, Wegener G, Guimarães FS, Mackie K, Lu H-C, Joca SRL. CB1 receptor silencing attenuates Ketamine-induced hyperlocomotion without compromising its antidepressant-like effects [Internet]. Cannabis and Cannabinoid Research. 2023 ; 8( 5): 768-778.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1089/can.2022.0072 -
Vancouver
Nunes PHG, LaMar J, Marques J dos S, Sartim AG, Silveira KM, Santos L, Wegener G, Guimarães FS, Mackie K, Lu H-C, Joca SRL. CB1 receptor silencing attenuates Ketamine-induced hyperlocomotion without compromising its antidepressant-like effects [Internet]. Cannabis and Cannabinoid Research. 2023 ; 8( 5): 768-778.[citado 2025 dez. 02 ] Available from: https://doi.org/10.1089/can.2022.0072 - Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects
- Avaliação de mecanismos comuns nos efeitos tipo-antidepressivos do canabidiol e da ketamina: possível envolvimento dos receptores CB1 e AMPA
- Targeting 2‐arachidonoylglycerol signalling in the neurobiology and treatment of depression
- Orexin A injection into the ventral medial prefrontal cortex induces antidepressant-like effects: possible involvement of local Orexin-1 and Trk receptors
- Antidepressant-like effect induced by Cannabidiol is dependent on brain serotonin levels
- Effects of inhibition of neuronal nitric oxide synthase(nNOS) on FOS expression in the rat brain
- Modulation of stress consequences by hippocampal monoaminergic, glutamatergic and nitrergic neurotransmitter systems
- Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-'HT IND.1A' receptors
- Sub-Chronic inhibition of nitric oxide synthase enhances total BDNF levels in rat hippocampus
- Inibição subcrônica da síntese de óxido nítrico (NO) diminui déficits comportamentais no modelo desamparo aprendido e aumenta a expressão de BDNF no hipocampo de ratos
Informações sobre o DOI: 10.1089/can.2022.0072 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
